Pratip K. Chattopadhyay

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial”.

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00029-7

N/A

0.493DataRank · unranked

14 citations

Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y. Song +11 more

Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes

JCI Insight(2020)10.1172/jci.insight.137066

N/A

0DataRank · unranked

20 citations

Andressa S. Laino, Aidan Winters, Jason Alexandre, Dan Freeman, Vinay Rao +4 more

Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome

eLife(2021)10.7554/elife.68371

N/A

0DataRank · unranked

38 citations

Lara Brambilla, Doua F. Azzouz, Ze Chen, Gisele V Baracho, Azlann Arnett +9 more

Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies

Frontiers in Immunology(2023)10.3389/fimmu.2023.1067352

N/A

0DataRank · unranked

4 citations

Ende Zhao, Daniel Freeman, Daniel Weissinger, Benjamin A. Krantz, Gregor Werba +7 more

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00798-z

N/A

0DataRank · unranked

9 citations

Russell K. Pachynski, Samuel R. Denmeade, Rahul Aggarwal, Jiehui Deng, Victor Adorno Febles +27 more